TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects December 30, 2011
TCL Archive Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH December 12, 2014
